Purchase Order 12505B23P0049

Award Date 3/3/23
Potential Completion Date 9/30/23
Potential Value $3.3K
Federal Agency
Midwest Area
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Midwest Area to Envigo Bioproducts Inc. for $22,655.00. The contract is for hybridoma services across three stages: Stage 1 - hybridoma services for 3 immunogens and 10 Balb/C mice; Stage 2 - fusion and subcloning services (option); and Stage 3 - cloning and small-scale antibody production (option). The contract has an ultimate completion date of May 31, 2025. Envigo...
This federal contract award to Envigo RMS LLC, doing business as Harlan Laboratories, is for a firm fixed-price purchase order to provide hybridoma services to the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Midwest Area. The contract has a ceiling value of $14,075.00 and covers three stages of services: Stage 1 - hybridoma services for 3 immunogens and 10 Balb/C mice; Stage 2 - fusion and subcloning services (option); and Stage 3 - cloning and small-scale...
The Centers for Disease Control and Prevention awarded Abcellera Biologics Inc. a definitive fixed price contract valued at $884,000 to provide a transgenic mouse model capable of generating humanized antibodies against influenza viruses. The original solicitation sought proposals for a mouse engineered with human immunoglobulin gene segments to better recapitulate the human antibody repertoire when testing candidate virus strains and developing antibodies. Under the contract, Abcellera will...
This firm fixed price purchase order, valued at $60,000, was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Leveragen Inc. of Worcester, Massachusetts. Under this contract, Leveragen will generate two lines of mice with specific CRISPR gene edits to the CTCF gene, containing either an R448Q mutation or a GRP>AAA mutation in amino acids 662-664. This work directly continues the solicitation to develop broadly neutralizing nanobodies...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $28,590.00 firm fixed-price purchase order contract to Abveris, Inc. to provide hybridoma generation cell panel services using mice. This sole-source contract was issued under the authority of 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, as no other source could provide the required proprietary Abveris hyperimmune DiversimAb mice and associated services. The contract...
This federal contract award is for Task Order 19 under a broader Delivery Order contract with Ozgene PTY LTD, an Australian company providing genetically modified mice and related services in support of biomedical research. The $67,700.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract provides for services such as...
This is a $29,727.26 firm fixed price contract awarded by the Defense Health Agency (DHA) to the Jackson Laboratory, a nonprofit biomedical research institution. The contract is for the provision of female mice strain 013062. The award does not have a set-aside designation. The Jackson Laboratory has extensive experience providing specialized research animals, particularly genetically engineered mouse models, to federal agencies like the NIH, DoD, and CDC to support their biomedical research...
This federal contract award is for the provision of live animals, specifically genetically modified mice, to support biomedical research. The prime contractor, Ozgene PTY LTD, an Australian company, is providing gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to various agencies within the U.S. Department of Health and Human Service's National Institutes of Health (NIH). The contract, with a ceiling value of $5,971.00, is a firm fixed-price...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $148,900.00 contract is for the provision of other functions including the creation of genetically modified knockout and...
This is a $87,990.00 firm fixed price purchase order awarded by the Health Resources and Services Administration (HRSA) to The Jackson Laboratory in Bar Harbor, Maine. The contract is for the supply of Hsd: Athymic Homozygous Nude- Foxn1nu Female Mice, 7-8 weeks old, with 25 mice to be delivered each month over a 12-month base period, plus four 12-month option periods. The mice are being provided to support the National Hansen's Disease Program Clinical Research Center, a civilian agency. The...

HYBRIDOMA PRODUCTION IN MICE - SOLE SOURCE

Posted 3/2/23, 12:00 AM